Cited by 11Genetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesSexual Differentiation and DisordersPrenatal Screening and Diagnostics

Neonatal detection of Turner syndrome by real-time PCR gene quantification of the ARSE and MAGEH1 genes

Open access
Corrêa, S.C., Rocha, M.N., Richeti, F., Kochi, C., Silva e Lima, L.A., Magalhães, M., Longui, C.A.·2014·Genetics and Molecular Research

Abstract

Turner syndrome (TS) is characterized by the presence of one full X chromosome and total or partial deletion of the second sex chromosome. Diagnosis of TS is often delayed, resulting in inappropriate treatment. Early diagnosis of TS using a neonatal screening test may improve preventive measures and treatment, thus improving patient quality of life. The goal of this study was to standardize a neonatal TS screening algorithm. Two study genes (ARSE and MAGEH1) and 1 normalizing gene (HBB) were used to detect the second X chromosome. We screened 996 newborns whose peripheral blood was collected and stored in filter paper. In addition, samples from 20 patients with confirmed diagnosis of TS were included in the study. Relative amounts of ARSE/HBB were determined using real-time polymerase chain reaction. The cutoff at the 5th percentile was arbitrarily set to indicate repetition of the test. The test was repeated in 51/1016 patients with ARSE/HBB < 0.81. For 10 samples with values persistently <0.81, we quantified the MAGEH1/HBB ratio. Values below the 95th percentile in TS patients (MAGEH1/HBB < 1.24) were considered to be inadequate. Only 6/996 NB showed inadequate values for the 2 studied genes, which were recalled for clinical evaluation and karyotype testing. Analysis of 20 patients diagnosed with TS allowed for identification of false-negatives and true-positives, establishing 95% sensitivity when the indicated cutoff values were used. In conclusion, our algorithm reached 95% detection sensitivity with an acceptable recall rate (0.6%), allowing for the detection of suspected TS cases in the neonatal period.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4238/2014.october.31.22

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Corrêa, S. C., Rocha, M. N., Richeti, F., Kochi, C., Silva e Lima, L. A., Magalhães, M., & Longui, C. A.
Affiliations
  • Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
  • Irmandade da Santa Casa de Misericórdia de São Paulo (BR)
Corresponding author
Longui, C.A.
Venue
Genetics and Molecular Research
Published
2014
Volume
13
Issue
4
Pages
9068-9076
ISSN
1676-5680 (ISSN-L)
OpenAlex
W2114675208
Cited by
11
References
19
Citations by year
2026: 3 · 2024: 1 · 2023: 1 · 2020: 1 · 2019: 2 · 2017: 3
FWCI
0.66
Type
journal article
Language
en
Open access
Locations
  • Genetics and Molecular Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
Keywords
Turner syndrome, newborn screening, screening cut-off values, neonates
MeSH terms
Algorithms, Arylsulfatases, Female, Genetic Testing, Humans, Infant, Newborn, Karyotyping, Microtubule-Associated Proteins, Neoplasm Proteins, Sensitivity and Specificity, Turner Syndrome, Reproducibility of Results, Sequence Analysis, DNA, beta-Globins, Karyotype, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review